EC Paediatrics

COVID-19 related multisystem inflammatory syndrome in children (MIS-C)   can present with cardiac manifestations, including coronary dilation and aneurysms. There is gray zone between Kawasaki and Kawasaki like illness with MIS-C in covid infection, with different pattern of coronary dilation [5]. The study describes 2 cases, 1^st one is 3-year-old patient with giant coronary aneurysms associated with COVID-19 related MIS-C, including the treatment with intravenous immunoglobulin, corticosteroids, and aspirin. 2^nd case is 13 years old girl with neglected type one truncus arteriosus presented with giant coronary aneurysms associated with COVID-19 related MIS-C and first presentation of diabetics ketoacidosis, including the treatment with intravenous immunoglobulin and insulin infusion [10]. This study emphasizes the awareness of early detection and aggressive management of MIS-C to prevent potentially life-threatening consequences.

 Keywords: Coronary Artery Aneurysms; COVID-19; MIS-C; Pediatrics; Diabetic Ketoacidosis

1. Dovc K, et al. “Impact of the COVID-19 pandemic on long-term trends in the prevalence of diabetic ketoacidosis at diagnosis of paediatric type 1 diabetes: an international multicentre study based on data from 13 national diabetes registries”. Diabetes and Endocrinology 10.11 (2022): 786-794.
2. Garg A., et al. “Giant coronary aneurysms in an infant: Dilemma of MIS-C case report”. Echocardiography 7 (2022): 950-953.
3. Grech V., et al. “A case of atypical Kawasaki disease with giant coronary artery aneurysm containing thrombus”. Images in Paediatric Cardiology 3 (2016): 9-15.
4. , et al. “Short-term cardiovascular complications of multi-system inflammatory syndrome in children (MIS-C) in adolescents and children”. Current Pediatrics Reports 9.4 (2021): 93-103.
5. Lima C., et al. “Hyperinflammatory response in COVID-19: A systematic review”. Viruses 2 (2023): 553.
6. Lucio verdoni., et al. “An outbreak of severe Kawasaki-like disease at the Italian epicenter of the SARS-CoV-2 epidemic: an observational cohort study”. Lancet 10239 (2020): 1771-1778.
7. Mustafa MR., et al. “Coronary aneurysms, myocardial dysfunction, and shock in a COVID-19 child, role of ECMO, immunomodulation, and cardiac CT”. Cardiology in the Young6 (2021): 1043-1047.
8. Naidu H., et al. “New-Onset type 1 diabetes in children during COVID-19: Multicenter Regional findings in the U.K”. Diabetes Care11 (2020): e170-e171.
9. Nakamura Y., et al. “Epidemiology and risk factors for giant coronary artery aneurysms identified after acute Kawasaki disease”. Pediatric Cardiology 4 (2021): 969-977.
10. , et al. “COVID-19 disease severity risk factors for pediatric patients in Italy”. Pediatrics 146.4 (2020): e2020009399.
11. S. Department of health and human services centers for disease control and prevention Atlanta, GA 30329 CSTE/CDC. “Multisystem inflammatory syndrome in children (MIS-C) associated with SARS-CoV-2 infection surveillance interim case reporting guide MIS-C” (2023).
12. Villacis-Nunez., et al. “Giant coronary aneurysms in MIS-C: case report”. Journal of the American College of Cardiology 3 (2021): 13.
13. Voicu C., et al. “Overlapping syndromes: Kawasaki-like disease in pediatric multisystem inflammatory syndrome vs. atypical Kawasaki disease. British or American? One case, many possibilities”. Romanian Journal of Cardiology 31 (2021): 897-902.
14. World Health Organization (WHO). “Coronavirus (COVID-19) Dashboard” (2022).